首页 | 本学科首页   官方微博 | 高级检索  
     


Neutropénies allo-immunes néonatales. Intérêt du traitement par facteur de croissance granuleux (G-CSF). Deux nouvelles observations
Authors:A. B  du, P. Rohrlich, C. Farnoux, M. Duval, O. Fenneteau, C. Boissinot, D. Pinquier, J. Cartron, E. Vilmer,Y. Aujard
Affiliation:1Service de néonatologie, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France;2ETS AP-HP site transfusionnel, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France;3service d'hématologie pédiatrique, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France;4service d'hématologie biologique, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France;5service de gynécologie-obstétrique, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France;6ETS AP-HP site transfusionnel, hôpital de Bicêtre, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France
Abstract:Alloimmune neonatal neutropenia is a rare event. Usually asymptomatic, it may however in some cases result in a severe sepsis. Treatment with recombinant granulocyte colony-stimulating factor (G-CSF) has been recently proposed.

Case reports

We report two new cases in infected newborns of a successful treatment of alloimmune neonatal neutropenia with G-CSF, resulting in complete neutrophil recovery in less than 72 hours. Moreover, the treatment was well tolerated.

Conclusion

The analysis of these two cases and of those previously reported indicates that G-CSF represents the first-choice treatment in this affection when infectious signs are present in the neonate.
Keywords:G-CSF   neutropé  nieAuthor Keywords: infant   newborn   agranulocytosis   immune complex disease   G-CSF
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号